Aims Clozapine is the most effective antipsychotic in treatment‐resistant schizophrenia. Clozapine causes weight gain and increased diabetes risk. The role of its metabolite norclozapine and clozapine:norclozapine ratio (CLZ/NCLZ) in metabolic effects has been debated.
Susanna Maria Rask +6 more
wiley +1 more source
Exploring the Social and Cultural Influences on Advance Care Planning Engagement for Patients Living With Cancer: A Hermeneutic Phenomenology Study. [PDF]
Lin CP, Huang CY, Peng JK, Chang HT.
europepmc +1 more source
Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon +7 more
wiley +1 more source
Perspectives on multimorbidity care provision among public hospital-based healthcare workers in Blantyre and Chiradzulu, Malawi: A qualitative study. [PDF]
Banda-Mtaula GT +14 more
europepmc +1 more source
Aims Non‐adherence to oral anticoagulants (OACs) is associated with significant morbidity and mortality. Mobile health (mHealth) interventions have been used to improve medication adherence across the three phases of initiation, implementation and persistence.
Non Davies +2 more
wiley +1 more source
Practical and clinical significance of the pharmacist-led antimicrobial stewardship. [PDF]
Umemura T.
europepmc +1 more source
The impact of medication shortages on paediatric care: A retrospective impact analysis
Aims Medication shortages are a growing global concern, with potentially greater consequences in paediatric patients because of the limited availability of safe, evidence‐based and appropriately formulated medication. This study aimed to evaluate the impact of medication shortages on paediatric patients by assessing the suitability and safety of ...
Maaike Johanna Rutten ‐ van Kranenburg +6 more
wiley +1 more source
Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy.
Urban C, Shore C, Desai S, Taylor L.
europepmc +1 more source
Investigation of Bisphosphonate Therapy for Osteoporosis: A Single-Center Cross-Sectional Study. [PDF]
Harada T, Kosaka S.
europepmc +1 more source
Current state of geriatric services in Georgia: education, policy gaps, and recommendations. [PDF]
Macharadze T.
europepmc +1 more source

